Nevena Rakovic
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nevena Rakovic has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Dunja Bjelogrlic
University Clinical Center of Vojvodina, Clinic of Hematology, Novi Sad
1 shared publication- Ivana Milosevic
Clinic for Hematology, University Clinical Center of Vojvodina, Novi Sad, Serbia
1 shared publication - Ivanka Percic
Faculty of Medicine, Clinic of Hematology, University of Novi Sad, University Clinical Center of Vojvodina, Novi Sad, Serbia
1 shared publication Nada Vlaisavljevic
University Clinical Center of Vojvodina, Clinic of Hematology, Novi Sad
1 shared publicationVelimir Tomic
University Clinical Center of Vojvodina, Clinic of Hematology, Novi Sad
1 shared publication
Latest Publications
- Open Access
- 1 January 2023
- Published by National Library of Serbia in Medicinski Pregled
- Vol. 76 (3-4) , 92-98
Interim positron emission tomography/computed tomography as a major prognostic factor of treatment outcome in newly diagnosed Hodgkin’s lymphoma and optimization of the therapeutic approach
Introduction. During the last decade, the interim positron emission tomography/computed tomography has emerged as the most important prognostic factor in patients with newly diagnosed Hodgkin’s lymphoma. The aim of this study was to analyze the treatment of patients at the Clinic of Hematology, University Clinical Center of Vojvodina, in order to evaluate the prognostic value of key risk factors, with a particular focus on the role of interim positron emission tomography/ computed tomography. Material and Methods. The study included 22 of 29 patients with a newly diagnosed classic Hodgkin’s lymphoma, i.e. all patients in whom the first therapy response assessment was based on positron emission tomography/computed tomography scan results. Relevant data were collected from medical records. Kaplan-Meier curves and log-rank tests were used for survival analysis. Univariate Cox regression was used to assess the predictive value of each variable for progression-free survival. Results. The study included 13 women (59.09%) and 9 men (40.91%), aged 18 to 73 years (median 39.5 years). Univariate analysis was used to analyze the statistical significance of three examined variables: gender, presence of B symptoms, and complete remission on interim positron emission tomography/computed tomography. Multivariate analysis was not performed due to the insufficient number of patients for adequate interpretation of results. Conclusion. Interim positron emission tomography/ computed tomography is the main prognostic factor in predicting treatment response and disease outcome in patients with newly diagnosed Hodgkin’s lymphoma.
- 1 January 2023
- Published by National Library of Serbia in Medicinski Pregled
- Vol. 76 (3-4) , 92-98
Open AccessInterim positron emission tomography/computed tomography as a major prognostic factor of treatment outcome in newly diagnosed Hodgkin’s lymphoma and optimization of the therapeutic approach
Introduction. During the last decade, the interim positron emission tomography/computed tomography has emerged as the most important prognostic factor in patients with newly diagnosed Hodgkin’s lymphoma. The aim of this study was to analyze the treatment of patients at the Clinic of Hematology, University Clinical Center of Vojvodina, in order to evaluate the prognostic value of key risk factors, with a particular focus on the role of interim positron emission tomography/ computed tomography. Material and Methods. The study included 22 of 29 patients with a newly diagnosed classic Hodgkin’s lymphoma, i.e. all patients in whom the first therapy response assessment was based on positron emission tomography/computed tomography scan results. Relevant data were collected from medical records. Kaplan-Meier curves and log-rank tests were used for survival analysis. Univariate Cox regression was used to assess the predictive value of each variable for progression-free survival. Results. The study included 13 women (59.09%) and 9 men (40.91%), aged 18 to 73 years (median 39.5 years). Univariate analysis was used to analyze the statistical significance of three examined variables: gender, presence of B symptoms, and complete remission on interim positron emission tomography/computed tomography. Multivariate analysis was not performed due to the insufficient number of patients for adequate interpretation of results. Conclusion. Interim positron emission tomography/ computed tomography is the main prognostic factor in predicting treatment response and disease outcome in patients with newly diagnosed Hodgkin’s lymphoma.